Literature DB >> 10454053

Effect of some antidepressants on glycaemia and insulin levels of normoglycaemic and alloxan-induced hyperglycaemic mice.

A Erenmemisoglu1, U K Ozdogan, R Saraymen, A Tutus.   

Abstract

Depression is an important problem among diabetic patients. We have investigated the effect of some antidepressant drugs on plasma glucose and insulin levels in normoglycaemic and alloxan-induced diabetic mice. For this purpose the effects of nortryptiline (as an example of a tricyclic antidepressant) and fluoxetine and sertraline (as examples of selective 5-HT re-uptake inhibitors) were examined on plasma glucose and insulin levels. Nortryptiline significantly increased glucose levels and reduced insulin levels in all animals. Although neither fluoxetine nor sertraline induced changes in insulin levels, both significantly reduced the blood glucose levels of mice. These results suggest that antidepressive treatment has important risks particularly for diabetics. Tricyclic antidepressants might induce an important decrease in glucose tolerance and worsen the control of diabetic patients. Selective 5-HT re-uptake inhibitors, on the other hand, might reduce plasma glucose independently of insulin levels. This point is particularly important and should be remembered when insulin or oral antidiabetic agents are administered to diabetics, because of the possible risk of hypoglycaemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10454053     DOI: 10.1211/0022357991772899

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  15 in total

1.  Use of antidepressant agents and the risk of type 2 diabetes.

Authors:  S Khoza; J C Barner; T M Bohman; K Rascati; K Lawson; J P Wilson
Journal:  Eur J Clin Pharmacol       Date:  2011-11-26       Impact factor: 2.953

Review 2.  Multiple chronic conditions and healthcare costs among adults.

Authors:  Usha Sambamoorthi; Xi Tan; Arijita Deb
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2015       Impact factor: 2.217

3.  Glucose intolerance with atypical antipsychotics.

Authors:  Karin Hedenmalm; Staffan Hägg; Malin Ståhl; Orjan Mortimer; Olav Spigset
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Tricyclic antidepressant imipramine reduces the insulin secretory rate in islet cells of Wistar albino rats through a calcium antagonistic action.

Authors:  M-H Antoine; D Gall; S N Schiffmann; P Lebrun
Journal:  Diabetologia       Date:  2004-04-16       Impact factor: 10.122

5.  Antidepressant effects on insulin sensitivity and proinflammatory cytokines in the depressed males.

Authors:  Yi-Chyan Chen; Wei-Win Lin; Yu-Jung Chen; Wei-Chung Mao; Yi-Jen Hung
Journal:  Mediators Inflamm       Date:  2010-05-18       Impact factor: 4.711

6.  The selective serotonin reuptake inhibitor sertraline enhances counterregulatory responses to hypoglycemia.

Authors:  Nicole M Sanders; Charles W Wilkinson; Gerald J Taborsky; Salwa Al-Noori; Wendi Daumen; Aryana Zavosh; Dianne P Figlewicz
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-03-11       Impact factor: 4.310

7.  Hypoglycemia associated with fluoxetine treatment in a patient with type 1 diabetes.

Authors:  Betina Biagetti; Rosa Corcoy
Journal:  World J Clin Cases       Date:  2013-08-16       Impact factor: 1.337

8.  A prospective observational study of obesity, body composition, and insulin resistance in 18 women with bipolar disorder and 17 matched control subjects.

Authors:  Sara B Fleet-Michaliszyn; Isabella Soreca; Amy D Otto; John M Jakicic; Andrea Fagiolini; David J Kupfer; Bret H Goodpaster
Journal:  J Clin Psychiatry       Date:  2008-10-21       Impact factor: 4.384

9.  The effects of sertraline on blood lipids, glucose, insulin and HBA1C levels: A prospective clinical trial on depressive patients.

Authors:  Murat Kesim; Ahmet Tiryaki; Mine Kadioglu; Efnan Muci; Nuri Ihsan Kalyoncu; Ersin Yaris
Journal:  J Res Med Sci       Date:  2011-12       Impact factor: 1.852

Review 10.  Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review.

Authors:  Katharine Barnard; Robert C Peveler; Richard I G Holt
Journal:  Diabetes Care       Date:  2013-10       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.